ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto

Item Number: BIOV2696-25
Unit of Measure: 25 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923724/image_1920?unique=67c7460

524.00 CHF 524.0 CHF 524.00 CHF

524.00 CHF

Not Available For Sale

    This combination does not exist.

    Current delivery time on request

    Manufacturer: BIOVISION
    Manufacturer Number: 2696-25
    Storage Temperature: Freezer (-20)

    ML239 is a selective inhibitor of breast cancer stem cells. It inhibits cancer stem cells with an IC₅₀ of 1.16 μM with 24-fold selec tivity against the control cell line. ML239 alters the expression of genes in the MAPK, NF-κB, and inflammatory cyto